Publicação: CDKN2A promoter hypermethylation in astrocytomas is associated with age and sex
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
CDKN2A promoter hypermethylation has been widely related to many cancers. In astrocytomas, although CDKN2A (p16INK4A protein) is often inactivated, there are still some controversial issues regarding the mechanism by which this alteration occurs. Thus, we analyzed a series of astrocytomas to assess the association between CDKN2A expression and methylation of grade I-IV tumors (WHO) and clinicopathological parameters. DNA extracted from formalin-fixed paraffin-embedded material of 93 astrocytic tumors was available for CDKN2A promoter methylation analysis and p16INK4A expression by methylation-specific PCR and immunohistochemistry, respectively. A strong negative correlation between nuclear and cytoplasmic immunostaining and CDKN2A promoter methylation was found. Additionally, a significant negative correlation between CDKN2A promoter methylation and age was observed; also, female patients had statistically more CDKN2A methylated promoters (p=0.036) than men. In conclusion, CDKN2A inactivation by promoter methylation is a frequent event in astrocytomas and it is related to the age and sex of patients. © 2013 Surgical Associates Ltd.
Descrição
Palavras-chave
Age, Astrocytic tumors, CDKN2A Methylation, Expression, P16, cyclin dependent kinase inhibitor 2A, DNA, adolescent, adult, age, aged, astrocytoma, child, DNA extraction, female, gene expression, human, human tissue, immunohistochemistry, major clinical study, male, preschool child, priority journal, promoter region, protein methylation, school child, sex difference
Idioma
Inglês
Como citar
International Journal of Surgery, v. 11, n. 7, p. 549-553, 2013.
